Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引：3

作者：

He, Rong ^{[1
]}

Chiou, Jonathan ^{[2
]}

Chiou, Allison ^{[3
]}

Chen, Dong ^{[1
]}

Chen, Constance P. ^{[4
]}

Spethman, Caroline ^{[5
]}

Bessonen, Kurt R. ^{[1
]}

Oliveira, Jennifer L. ^{[1
]}

Nguyen, Phuong L. ^{[1
]}

Reichard, Kaaren K. ^{[1
]}

Hoyer, James D. ^{[1
]}

Althoff, Simon D. ^{[1
]}

Roh, Dana J. ^{[1
]}

Miller, Mechelle A. ^{[1
]}

Yuan, Ji ^{[1
]}

Olteanu, Horatiu ^{[1
]}

Begna, Kebede ^{[6
]}

Tefferi, Ayalew ^{[6
]}

Alkhateeb, Hassan ^{[6
]}

Patnaik, Mrinal M. ^{[6
]}

Litzow, Mark R. ^{[6
]}

Al-Kali, Aref ^{[6
]}

Viswanatha, David S. ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA

[2] Dartmouth Coll, Hanover, NH USA

[3] Wellesley Coll, Wellesley, MA USA

[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA

[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA

[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA

来源：

BLOOD CANCER JOURNAL | 2022年 / 12卷 / 01期

关键词：

CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;

D O I：

10.1038/s41408-022-00612-w

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[1] Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
Rong He
Jonathan Chiou
Allison Chiou
Dong Chen
Constance P. Chen
Caroline Spethman
Kurt R. Bessonen
Jennifer L. Oliveira
Phuong L. Nguyen
Kaaren K. Reichard
James D. Hoyer
Simon D. Althoff
Dana J. Roh
Mechelle A. Miller
Ji Yuan
Horatiu Olteanu
Kebede Begna
Ayalew Tefferi
Hassan Alkhateeb
Mrinal M. Patnaik
Mark R. Litzow
Aref Al-Kali
David S. Viswanatha
Blood Cancer Journal, 12
[2] Prognostic molecular markers in myelodysplastic syndromes
Neukirchen, Judith
Haas, Rainer
Germing, Ulrich
EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (05) : 563 - 575
[3] Diagnostic Value of Molecular Markers in the Work-up of Myelodysplastic Syndromes
Chiou, J.
He, R.
Chiou, A.
Chen, D.
Viswanatha, D.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (11): : S23 - S24
[4] Molecular features and prognostic value of RAS mutations in patients with myelodysplastic syndromes
黄慧君
ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (04) : 233 - 233
[5] MOLECULAR FEATURES A PROGNOSTIC VALUE OF RAS MUTATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Huang, H.
Li, B.
Qin, T.
Xu, Z.
Hu, N.
Pan, L.
Qu, S.
Liu, D.
Zhang, Y.
Xiao, Z.
LEUKEMIA RESEARCH, 2021, 108 : S21 - S21
[6] Prognostic Markers of Myelodysplastic Syndromes
Veryaskina, Yuliya Andreevna
Titov, Sergei Evgenievich
Kovynev, Igor Borisovich
Pospelova, Tatiana Ivanovna
Zhimulev, Igor Fyodorovich
MEDICINA-LITHUANIA, 2020, 56 (08): : 1 - 16
[7] The diagnostic and prognostic value of bone marrow immunostaining in myelodysplastic syndromes
Deliliers, GL
Annaloro, C
Soligo, D
Oriani, A
LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) : 231 - +
[8] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
Duong, Vu H.
Padron, Eric
Al Ali, Najla H.
Lancet, Jeffrey E.
Hall, Jeff
Kwok, Brian
Zhang, Ling
Epling-Burnette, Pearlie K.
List, Alan F.
Komrokji, Rami S.
ANNALS OF HEMATOLOGY, 2018, 97 (02) : 247 - 254
[9] The prognostic value of thrombocytopenia in patients with primary myelodysplastic syndromes
Zhijian, X.
Zefen, X.
Yuedan, C.
LEUKEMIA RESEARCH, 2013, 37 : S77 - S77
[10] The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes
Vu H. Duong
Eric Padron
Najla H. Al Ali
Jeffrey E. Lancet
Jeff Hall
Brian Kwok
Ling Zhang
Pearlie K. Epling-Burnette
Alan F. List
Rami S. Komrokji
Annals of Hematology, 2018, 97 : 247 - 254

← 1 2 3 4 5 →